Alerts will be sent to your verified email
Verify Email
ONESOURCE
|
Onesource Specialty
|
Eris Lifesciences
|
Concord Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-74.5 % | 19.85 % | 20.02 % |
|
5yr average Equity Multiplier
|
2.76 | 1.5 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
0.07 | 0.58 | 0.52 |
|
5yr Avg Net Profit Margin
|
-824.62 % | 25.85 % | 30.81 % |
|
Price to Book
|
3.77 | 7.81 | 11.12 |
|
P/E
|
0.0 | 63.36 | 54.25 |
|
5yr Avg Cash Conversion Cycle
|
-239.17 Days | -99.43 Days | 37.41 Days |
|
Inventory Days
|
954.68 Days | 26.22 Days | 80.96 Days |
|
Days Receivable
|
62.7 Days | 61.69 Days | 111.87 Days |
|
Days Payable
|
620.72 Days | 164.23 Days | 173.13 Days |
|
5yr Average Interest Coverage Ratio
|
-3.99 | 94.87 | 137.55 |
|
5yr Avg ROCE
|
-15.49 % | 21.14 % | 25.59 % |
|
5yr Avg Operating Profit Margin
|
-156.51 % | 34.25 % | 42.97 % |
|
5 yr average Debt to Equity
|
1.21 | 0.29 | 0.04 |
|
5yr CAGR Net Profit
|
11.09 % | 5.74 % | 12.77 % |
|
5yr Average Return on Assets
|
-26.39 % | 15.49 % | 15.93 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
34.25 % | 54.85 % | 44.08 % |
|
Share Pledged by Promoters
|
20.06 % | 18.51 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.52 % | 2.19 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.7 % | 6.48 % | -0.42 % |